REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, ...
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the ...
Integration boosts Grid AI’s deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% ...
Scientists found that DNA’s phosphate groups can direct chemical reactions to make the correct mirror-image form of drug ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Greetings, and welcome to the Codexis Third Quarter 2025 Earnings ...
Discover Codexis' Q3 2025 earnings highlights, strategic shift with Merck, and new leadership—positioning for growth in oligonucleotide manufacturing.
Burmese pythons possess a remarkable ability to swallow and digest prey significantly larger than their heads. This ...
Jordan's Hakeem Program Sets Regional Benchmark In Digital Healthcare Transformation. Amman, Nov. 1 (Petra) - Over the past 15 years, Jordan's national Hakeem program has emerged as a pioneering model ...
The molecular cloning workflow requires QC checkpoints both before and after restriction endonuclease digestion to minimize ...
A new platform developed at Scripps Research enables fast, scalable protein evolution. This potentially opens the door to new therapies and diagnostics. In addition, the technology may aid scientists ...
Syracuse University researchers are developing a new way to guide the release of chemotherapy drugs to tumors using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback